ArticleThe Journal of clinical endocrinology and metabolism2023

Emergence of a New Glucoregulatory Mechanism for Glycemic Control With Dapagliflozin/Exenatide Therapy in Type 2 Diabetes.

Eugenio Cersosimo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.